update Updates

Federal Byetta, Victoza, Januvia Lawsuits Consolidated in California

Byetta Januvia and Victoza lawsuits were consolidated on Aug. 28 in federal district court in California according to court documents. The U.S. Judicial Panel on Multidistrict Litigation ordered the consolidation of 53 nationwide lawsuits involving some diabetes drugs including Byetta  Januvia and Victoza all of which are allegedly linked to… Read more

Federal Judicial Panel Considering Byetta Lawsuit Consolidation

The Byetta lawyers at RLG report that a federal judicial panel is still considering the consolidation of Byetta lawsuits according to court documents. The Judicial Panel on Multidistrict Litigation was set to begin discussions on July 25 to investigate a consolidation of proceedings for pretrial efficiency. Byetta manufactured by Bristol-Myers Squibb subsidiary… Read more

Federal Byetta, Victoza, Januvia Lawsuits Could See Consolidation This Month

On July 25 a judicial panel will consider the consolidation of federal Byetta Januvia and Victoza lawsuits for pretrial purposes according to court documents in In RE: Incretin Mimetics Products Liability Litigation (MDL-2452; U.S. Judicial Panel on Multidistrict Litigation). RLG a law firm that represents clients in Byetta Victoza and Januvia lawsuits… Read more

BMJ Study Looks at Risks of Byetta, Januvia

A June 2013 British Medical Journal report has asserted that diabetes drugs such as Byetta and Januvia could be riskier than previously thought because drug makers allegedly withheld adverse effects data according to MedPage Today. This comes about a week after the American Diabetes Association called for a safety review of… Read more

Drugmakers’ to Cooperate With American Diabetes Association’s Safety Review of Byetta, Januvia, Victoza

Following the American Diabetes Association’s call for a safety review of diabetes drugs because of potential pancreatic cancer links the makers of Byetta Januvia and Victoza announced June 12 they will voluntarily participate in the new evaluation of clinical data according to Reuters. The Rottenstein Law Group LLP which maintains Byetta  Januvia and Victoza lawsuit pages… Read more

Study Links Diabetes Drug Byetta to Cancer Risks

A recent report published by the Institute for Safe Medication Practices said users of Type 2 diabetes drugs such as Byetta were 25 times more likely to develop pancreatic cancer than those who used other diabetes drugs. RLG which is accepting clients in Byetta lawsuits maintains a Byetta Legal Information Center on its website designed… Read more

Study Says Byetta Side Effects Could Include Damage to the Pancreas

A recent study says that diabetes drug Byetta manufactured by Amylin Pharmaceutical in conjunction with Eli Lilly and Company could cause damage to the pancreas—even cancer. RLG which is accepting clients in Byetta lawsuits maintains a Byetta Legal Information Center on its website designed to provide more information on Byetta side effects and… Read more

RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.